Message from the Organizing Committee of the International Workshop on Liver and Gut Fibrosis in light of the current COVID-19 crisis: 

Although it is difficult to predict how the present situation will develop, given that the workshop is still 3 months away we are continuing with its organization.

Naturally, if any changes occur regarding this situation we will publish the news immediately.

We sincerely hope that this crisis will be resolved as soon as possible and we can see each other in Valencia on June 18.

             

Prof. Juan V. Esplugues

Head of the
Scientific Committee

www.pharmacologyvalencia.com  

 


 

 

 

 

 

 

 

 

 

      

Fibrosis is a global health problem characterized by an excessive growth of fibrous tissue due to chronic inflammation and altered tissue remodelling and repair processes. It occurs in various organs, including the lung, kidney, liver and intestine, and is a key component of important pathologies, including cystic fibrosis, Crohn’s Disease and Non-Alcoholic Fatty Liver Disease. Despite the huge advances made by research in recent years, the molecular mechanisms involved in the development of fibrosis are still unclear; indeed, it would seem that different mechanisms are involved in each of the affected organs. Importantly, few effective therapeutic options are available, and only for some organs, such as the lung and kidney, with no anti-fibrotic pharmacological treatments available for the intestine or liver. The International Workshop on Liver and Gut Fibrosis – the first to take place, and endorsed by EASL – has been organised to bring together basic scientists and clinical experts working in the field with the purpose of focusing on the molecular mechanisms involved in the different types of fibrosis and determining those that are common to different organs, particularly the gut and liver. In this way, the workshop has been designed to explore options that might improve current therapeutic approaches and to identify new pharmacological targets that will relieve the burden of fibrosis for millions of patients.


We invite those of you who are interested in this topic to join us and some of the most relevant European researchers in the field here in the beautiful Mediterranean city of Valencia, at the beginning of summer, probably one of the best times of the year to visit. We look forward to seeing you.


 

 




 
 


IMPORTANT DATES    

Abstract submission:   
1 January 2020 - 16 March 2020    

Deadline for travel  grant application:  
28 February 2020   

Notification of abstract acceptance:   
30 April 2020   

 

REGISTRATION FEES    

PhD students and   
medical residents: 100.00 €   

Postdoctoral/senior researchers   
and medical consultants: 200.00 €   

 

REGISTRATION NOW OPEN    

Registration period:   
from 1-12-2019 to 1-06-2020    
 Register      

 
     

 

 

 

 

     
     

 

 

 


Last places!
Registration period: 1-12-2019 until 1-06-2020
 Register
Abstracts

Abstracts can be submitted here

  • Looking for PhD students. https://t.co/mJlE6CKEfL Buscamos estudiante predoctoral. https://t.co/hdtwYLS5dD Contact… https://t.co/nnJvmMMKey
    27 days ago
  • RT @CIPFciencia: Today is #RareDiseaseDay! There are over 300 million people worldwide living with a rare disease. At @CIPFciencia we work…
    30 days ago
  • Have you sent your abstract to the International Workshop on Liver and Gut Fibrosis?? If not, get a move on! The de… https://t.co/AU8xsPq0OZ
    30 days ago

Organizers, sponsors, collaborators